Critical Reviews in Oncology / Hematology
Volume 81, Issue 2 , Pages 103-122, February 2012

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice

  • Elisa Giovannetti

      Affiliations

    • VU University Medical Center, Amsterdam, The Netherlands
    • Department Internal Medicine, University of Pisa, Pisa, Italy
    • Corresponding Author InformationCorresponding author at: Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Tel.: +31 20 4442267; fax: +31 20 4443844.
    • ,
  • Ayse Erozenci

      Affiliations

    • VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Jorn Smit

      Affiliations

    • VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Romano Danesi

      Affiliations

    • Department Internal Medicine, University of Pisa, Pisa, Italy
    • ,
  • Godefridus J. Peters

      Affiliations

    • VU University Medical Center, Amsterdam, The Netherlands

Accepted 31 March 2011. published online 06 May 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1040-8428(11)00089-8

doi:10.1016/j.critrevonc.2011.03.010

Critical Reviews in Oncology / Hematology
Volume 81, Issue 2 , Pages 103-122, February 2012

Article Tools

* Image Usage & Resolution